IBDEI1B0 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23405,1,5,0)
 ;;=5
 ;;^UTILITY(U,$J,358.3,23406,0)
 ;;=459.10^^139^1436^31
 ;;^UTILITY(U,$J,358.3,23406,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23406,1,3,0)
 ;;=3^459.10
 ;;^UTILITY(U,$J,358.3,23406,1,5,0)
 ;;=5^Post Phlebotic Syndrome
 ;;^UTILITY(U,$J,358.3,23406,2)
 ;;=Post Phlebotic Syndrome^328597
 ;;^UTILITY(U,$J,358.3,23407,0)
 ;;=719.7^^139^1436^21
 ;;^UTILITY(U,$J,358.3,23407,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23407,1,3,0)
 ;;=3^719.7
 ;;^UTILITY(U,$J,358.3,23407,1,5,0)
 ;;=5^Difficulty In Walking
 ;;^UTILITY(U,$J,358.3,23407,2)
 ;;=^329945
 ;;^UTILITY(U,$J,358.3,23408,0)
 ;;=453.40^^139^1436^8
 ;;^UTILITY(U,$J,358.3,23408,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23408,1,3,0)
 ;;=3^453.40
 ;;^UTILITY(U,$J,358.3,23408,1,5,0)
 ;;=5^Deep vein thrombosis lower extremity
 ;;^UTILITY(U,$J,358.3,23408,2)
 ;;=^338554
 ;;^UTILITY(U,$J,358.3,23409,0)
 ;;=357.2^^139^1436^20
 ;;^UTILITY(U,$J,358.3,23409,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23409,1,3,0)
 ;;=3^357.2
 ;;^UTILITY(U,$J,358.3,23409,1,5,0)
 ;;=5^Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,23409,2)
 ;;=^96321
 ;;^UTILITY(U,$J,358.3,23410,0)
 ;;=250.60^^139^1436^4
 ;;^UTILITY(U,$J,358.3,23410,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23410,1,3,0)
 ;;=3^250.60
 ;;^UTILITY(U,$J,358.3,23410,1,5,0)
 ;;=5^DM II w/ Neuro Manif
 ;;^UTILITY(U,$J,358.3,23410,2)
 ;;=^331803
 ;;^UTILITY(U,$J,358.3,23411,0)
 ;;=250.70^^139^1436^6
 ;;^UTILITY(U,$J,358.3,23411,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23411,1,3,0)
 ;;=3^250.70
 ;;^UTILITY(U,$J,358.3,23411,1,5,0)
 ;;=5^DM II w/ Periph Circ Disorder
 ;;^UTILITY(U,$J,358.3,23411,2)
 ;;=^331807
 ;;^UTILITY(U,$J,358.3,23412,0)
 ;;=250.80^^139^1436^5
 ;;^UTILITY(U,$J,358.3,23412,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23412,1,3,0)
 ;;=3^250.80
 ;;^UTILITY(U,$J,358.3,23412,1,5,0)
 ;;=5^DM II w/ Oth Manif
 ;;^UTILITY(U,$J,358.3,23412,2)
 ;;=^331811
 ;;^UTILITY(U,$J,358.3,23413,0)
 ;;=692.9^^139^1437^1
 ;;^UTILITY(U,$J,358.3,23413,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23413,1,3,0)
 ;;=3^692.9
 ;;^UTILITY(U,$J,358.3,23413,1,5,0)
 ;;=5^Eczema
 ;;^UTILITY(U,$J,358.3,23413,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,23414,0)
 ;;=691.8^^139^1437^2
 ;;^UTILITY(U,$J,358.3,23414,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23414,1,3,0)
 ;;=3^691.8
 ;;^UTILITY(U,$J,358.3,23414,1,5,0)
 ;;=5^Eczema, allergic
 ;;^UTILITY(U,$J,358.3,23414,2)
 ;;=^87342
 ;;^UTILITY(U,$J,358.3,23415,0)
 ;;=782.3^^139^1437^3
 ;;^UTILITY(U,$J,358.3,23415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23415,1,3,0)
 ;;=3^782.3
 ;;^UTILITY(U,$J,358.3,23415,1,5,0)
 ;;=5^Edema (any site)
 ;;^UTILITY(U,$J,358.3,23415,2)
 ;;=^38340
 ;;^UTILITY(U,$J,358.3,23416,0)
 ;;=726.70^^139^1437^4
 ;;^UTILITY(U,$J,358.3,23416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23416,1,3,0)
 ;;=3^726.70
 ;;^UTILITY(U,$J,358.3,23416,1,5,0)
 ;;=5^Enthesopathy of ankle & tarsus, unspecified
 ;;^UTILITY(U,$J,358.3,23416,2)
 ;;=^272548
 ;;^UTILITY(U,$J,358.3,23417,0)
 ;;=736.72^^139^1437^5
 ;;^UTILITY(U,$J,358.3,23417,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23417,1,3,0)
 ;;=3^736.72
 ;;^UTILITY(U,$J,358.3,23417,1,5,0)
 ;;=5^Equinus deformity of foot, acquired
 ;;^UTILITY(U,$J,358.3,23417,2)
 ;;=^272744
 ;;^UTILITY(U,$J,358.3,23418,0)
 ;;=726.91^^139^1437^6
 ;;^UTILITY(U,$J,358.3,23418,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23418,1,3,0)
 ;;=3^726.91
 ;;^UTILITY(U,$J,358.3,23418,1,5,0)
 ;;=5^Exostosis of unspecified site
 ;;^UTILITY(U,$J,358.3,23418,2)
 ;;=^43688
 ;;^UTILITY(U,$J,358.3,23419,0)
 ;;=728.71^^139^1438^1
